Sinus Dilation Devices Market Report 2025

The sinus dilation devices market size has grown strongly in recent years. It will grow from $2.94 billion in 2024 to $3.18 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to chronic sinusitis prevalence, patient preference for minimally invasive procedures, rising awareness, healthcare expenditure, aging population.

The sinus dilation devices market size is expected to see strong growth in the next few years. It will grow to $4.49 billion in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing cases of chronic rhinosinusitis, preference for outpatient procedures, shift towards value-based healthcare, telemedicine and remote consultations, rise in allergies and environmental factors. Major trends in the forecast period include smart devices and robotics, remote monitoring and follow-ups, hybrid procedures, patient-centric approaches, and regulatory advancements.

The sinus dilation devices market is experiencing growth driven by the prevalence of chronic sinusitis. Chronic sinusitis, marked by prolonged inflammation and swelling of the sinuses lasting at least 12 weeks, is a condition addressed by sinus dilation devices such as balloon sinuplasty. These devices facilitate the treatment of chronic sinusitis by employing a balloon to open nasal passages and alleviate sinus blockages. In January 2023, Frontiers reported a 10% prevalence of chronic sinusitis among the Chinese population, with urban and rural areas witnessing 18% and 27% prevalence, respectively. Moreover, Pulse Notes, in February 2023, noted that chronic sinusitis affected 10% of the UK population, with 4% exhibiting chronic sinusitis with nasal polyps. Thus, the increasing prevalence of sinusitis is a driving factor for the sinus dilation devices market.

The sinus dilation devices market is anticipated to witness growth due to the rise in healthcare expenditures. Healthcare expenditures, encompassing costs related to health services, family planning, and emergency aid, contribute to advanced technology development and minimally invasive treatments for sinus-related conditions. According to the Centers for Medicare & Medicaid Services in December 2023, US healthcare spending reached $4.5 trillion in 2022, with a per-person expenditure of $13,493. This accounted for 17.3% of the country's Gross Domestic Product. Consequently, the increasing healthcare expenditures are propelling the sinus dilation devices market.

Leading companies in the sinus dilation devices market are launching technologically advanced products, such as flexible balloon sections, to enhance patient outcomes and improve procedural efficiency. These flexible balloon devices are engineered to provide better access and adaptability within the intricate anatomy of the sinuses, facilitating more effective dilation during surgical procedures. For example, in February 2023, Medtronic PLC, an Ireland-based healthcare technology company, introduced the NuVent Eustachian Tube Dilation Balloon, which received approval from the Food and Drug Administration (FDA), a U.S. federal agency. This medical device is designed to address Eustachian tube dysfunction (ETD), a condition that can cause symptoms like ear pain, pressure, and hearing difficulties. The NuVent balloon features a flexible section that allows for customized positioning based on the patient's anatomical structure, offering a less invasive alternative compared to traditional surgical methods, which may be more suitable for patients who require treatment beyond medications like nasal sprays.

Key players in the sinus dilation devices market are also launching advanced products such as electromagnetically navigated blades to enhance precision in sinus surgeries and improve patient outcomes. These electromagnetically navigated blades are sophisticated surgical instruments designed to increase accuracy during sinus surgeries and other minimally invasive procedures. For instance, in August 2022, Acclarent, a U.S.-based medical device company, unveiled the TruDi Shaver Blade, which gained approval from the FDA. The TruDi Shaver Blade is a single-use, electromagnetically navigated instrument aimed at enhancing surgical techniques related to ear, nose, and throat (ENT) procedures, particularly for sinus surgeries. It is designed to integrate seamlessly with the TruDi Navigation system, allowing for real-time tracking and guidance during surgical procedures, thereby improving precision in tissue removal.

In May 2022, Medtronic PLC, an Ireland-based medical device company, acquired Intersect ENT, a US-based manufacturer of sinus implant products and technologies, for an undisclosed amount. This strategic acquisition aims to expand Medtronic's comprehensive portfolio in ear, nose, and throat (ENT) and sinus procedure supplies.

Major companies operating in the sinus dilation devices market include Johnson & Johnson Co, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Smith & Nephew PLC, B. Braun Melsungen AG, Nordson MEDICAL Corp, Cook Medical Inc., Karl Storz GmbH & Co. KG, Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Richard Wolf GmbH, Acclarent Inc., Intersect ENT Inc., Sklar Corporation, SinuSys Corporation, XION GmbH, Innaccel Technologies Pvt. Ltd, Innovia Medical, Poba Medical.

North America was the largest region in the sinus dilation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the sinus dilation devices market report during the forecast period. The regions covered in the sinus dilation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sinus dilation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sinus dilation devices are medical instruments designed to expand or open sinus passages, facilitating improved airflow and drainage while alleviating symptoms associated with sinus blockage. These devices are utilized in the treatment of various sinus conditions, including chronic sinusitis and nasal congestion.

The primary types of sinus dilation devices encompass balloon sinus dilation devices, endoscopes, functional endoscopic sinus surgery (FESS) instrument sets, sinus stents or implants, and others. Balloon sinus dilation devices specifically target the opening of blocked or narrowed sinus passages, addressing conditions such as chronic sinusitis. These devices contribute to enhanced drainage and airflow. The major procedures involve standalone and hybrid approaches, and they find application in both adult and pediatric cases. End-users of sinus dilation devices include hospitals, ENT clinics, and other healthcare facilities.

The sinus dilation devices market research report is one of a series of new reports that provides sinus dilation devices market statistics, including sinus dilation devices industry global market size, regional shares, competitors with a sinus dilation devices market share, detailed sinus dilation devices market segments, market trends and opportunities, and any further data you may need to thrive in the sinus dilation devices industry. This sinus dilation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sinus dilation devices market consists of sales of sinus irrigation devices, sinus guide catheters, balloon inflation devices, catheter hands, sinus treatment kits, and nasal forceps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.